mRNA vaccines induce rapid antibody responses in mice
Abstract mRNA vaccines can be developed and produced quickly, making them prime candidates for immediate outbreak responses. Furthermore, clinical trials have demonstrated rapid protection following mRNA vaccination. Thus, we sought to investigate how quickly mRNA vaccines elicit antibody responses...
Үндсэн зохиолчид: | Makda S. Gebre, Susanne Rauch, Nicole Roth, Janina Gergen, Jingyou Yu, Xiaowen Liu, Andrew C. Cole, Stefan O. Mueller, Benjamin Petsch, Dan H. Barouch |
---|---|
Формат: | Өгүүллэг |
Хэл сонгох: | English |
Хэвлэсэн: |
Nature Portfolio
2022-08-01
|
Цуврал: | npj Vaccines |
Онлайн хандалт: | https://doi.org/10.1038/s41541-022-00511-y |
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
-н: Susanne Rauch, зэрэг
Хэвлэсэн: (2021-04-01) -
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses
-н: Nicole Roth, зэрэг
Хэвлэсэн: (2022-08-01) -
mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice
-н: Charlie Fricke, зэрэг
Хэвлэсэн: (2024-12-01) -
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models
-н: Nicole Roth, зэрэг
Хэвлэсэн: (2023-01-01) -
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models
-н: Björn Corleis, зэрэг
Хэвлэсэн: (2023-02-01)